Tirzepatide × Reta One Labs - Lab Test, May 2026
Test results
About this test
This independent RP-HPLC lab test confirms Tirzepatide 30mg from Reta One Labs at 99.956% purity. The analysis was conducted by Kovera Labs on May 13, 2026.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. The tested quantity of 32.25mg demonstrates overage relative to the stated 30mg label claim. A purity level of 99.956% indicates minimal impurities and pharmaceutical-grade synthesis quality. Heavy metal screening confirmed negative results for arsenic, cadmium, lead, and mercury. Endotoxin safety passed at ≤0.5 EU/mL.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.